ALK+ ALCL in the setting of adalimumab-related hidradenitis suppurativa.

Published in: Clinical case reports (2023)

This ALK-positive anaplastic large cell lymphoma (ALCL) case highlights the importance of considering ALCL in the setting of iatrogenic immunosuppression in hidradenitis suppurativa patients. Diagnosis of ALCL can be challenging in situations with very low viability/cellularity, negative CD3 and/or other T-cell markers, and immunosuppression.

Keyphrases

hidradenitis suppurativa
end stage renal disease
ejection fraction
single cell
chronic kidney disease
newly diagnosed
peritoneal dialysis
systemic lupus erythematosus
drug induced